Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...

Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a modest uptick, ending the day at $422 which represents a slight increase of $5.04 or 1.21% from the prior close of $416.96. The stock opened at $422.73 ...

Vertex specializes in corporate tax compliance software, targeting a $22B global TAM with a focus on enterprise and SMB ...

Vertex Pharmaceuticals (VRTX ... its future stream of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock ...

According to InvestingPro analysis, the company stands as a prominent ... This readout is viewed as a significant potential catalyst for Vertex's stock, as success in chronic pain could ...

Vertex stock plummeted Thursday after the ... comparison between suzetrigine and a placebo. Further, ad hoc analysis showed there was "variability in the placebo response across study sites ...

Vertex Pharmaceuticals Inc. closed 19.80% below its 52-week high of $519.88, which the company reached on November 8th.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

According to InvestingPro analysis, the company stands as a prominent player ... This readout is viewed as a significant potential catalyst for Vertex's stock, as success in chronic pain could ...